Prostaglandin J2 and 15-deoxy-Δ12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells

Cancer Research

Volumn 59, Issue 11, 1999, Pages 2739-2746

  Chinery, Rebecca ^a   Coffey, Robert J ^a,b   Graves Deal, Ramona ^a   Kirkland, Susan C ^c   Sanchez, Stephanie C ^a   Zackert, William E ^a   Oates, John A ^a   Morrow, Jason D ^a,d  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN J2; PROSTAGLANDIN SYNTHASE; 15 DEOXY DELTA(12,14) PROSTAGLANDIN J2; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J2; 9-DEOXY-DELTA-9-PROSTAGLANDIN D2; ANTIINFECTIVE AGENT; CYCLOOXYGENASE 2; DRUG DERIVATIVE; ISOENZYME; LIPID; MEMBRANE PROTEIN; PROSTAGLANDIN; PROSTAGLANDIN D2; PTGS2 PROTEIN, HUMAN; TETRACYCLINE;

ARTICLE; CELL PROLIFERATION; COLON CARCINOGENESIS; COLORECTAL CANCER; ENZYME INDUCTION; GROWTH STIMULATION; HUMAN; HUMAN CELL; MITOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL CULTURE; CELL DIVISION; COLORECTAL TUMOR; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PATHOLOGY;

ANTI-BACTERIAL AGENTS; CELL DIVISION; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; HUMANS; ISOENZYMES; LIPIDS; MEMBRANE PROTEINS; PROSTAGLANDIN D2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; TETRACYCLINE; TUMOR CELLS, CULTURED;

EID: 0033137322     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Levy, G. N. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs and colon cancer. FASEB J., 11: 234-247, 1997.
2. Eberhart, C. E., and DuBois, R. N. Eicosanoids and the gastrointestinal tract. Gastroenterology, 109: 285-301, 1995.
3. O'Neill, G., and Hutchinson, A. F. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett., 330: 156-160, 1993.
4. Williams, C. W., and DuBois, R. N. Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol., 270: G393-G400, 1996.
5. Sano, H., Kawahito, Y., Wilder, R., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hia, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55: 3785-3789, 1995.
6. DuBois, R. N., Radhika, A., Reddy, B. S., and Entingh, A. J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology, 110: 1259-1262, 1996.
7. Williams, C. S., Luongo, C., Radhika, A., Zhang, T., Lamps, L. W., Nanney, L. B., Beauchamp, R. D., and DuBois, R. N. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology, 111: 1134-1140, 1996.
8. Campbell, W. B., and Halushka, P. V. Lipid derived autacoids. Eicosanoids and platelet-activating factor. In: J. G. Hardman and L. E. Limbird (eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics, Ed. 9, pp. 601-616. New York: McGraw-Hill, 1996.
9. Santoro, M. G., Philpott, G. W., and Jaffee, B. M. Inhibition of tumour growth in vivo and in vitro by prostaglandin E. Nature (Lond.), 263: 777-779, 1976.
10. 2-isoprostane receptors on rat vascular smooth muscle cells. Am. J. Physiol., 264: C1619-C1624, 1993.
11. Breyer, M. D., Jacobson, H. R., and Breyer, R. M. Functional and molecular aspects of renal prostaglandin receptors. J. Am. Soc. Nephrol., 7: 8-17, 1996.
12. Coffey, R. J., Hawkey, C. J., Damstrup, L., Graves-Deal, R., Daniel, V. C., Dempsey, P. J., Chinery, R., Kirkland, S. C., DuBois, R. N., Jetton, T. L., and Morrow, J. D. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc. Natl. Acad. Sci. USA, 94: 657-662, 1997.
13. Chan, T. A., Morin, P. I., Vogelstein, B., Kanzler, K. W. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 95: 681-686, 1998.
14. Qiao, L., Shiff, S. I., and Rigas, B. Sulindac sulfide inhibits the proliferation of colon cancer cells: diminished expression of the proliferation markers PCNA and Ki-67. Cancer Lett., 115: 229-234, 1997.
15. Shiff, S. J., Koutsos, M. I., Qiao, L., and Rigas, B. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp. Cell Res., 222: 179-188, 1996.
16. 2. J. Biol. Chem., 258: 11713-11718, 1983.
17. 2 and related compounds: an update. Prostaglandins Leukotrienes Essent. Fatty Acids, 47: 1-12, 1992.
18. 2α treatment. Exp. Cell Biol., 55: 18-27, 1987.
19. Marsh, K. A., Stamp, G. W. H., and Kirkland, S. C. Isolation and characterization of multiple cell types from a single human colonic carcinoma: tumourigenicity of these cell types in a xenograft system. J. Pathol., 170: 441-450, 1993.
20. Gossen, M., Freundlieb, S., Bender, G., Muller, G. Hillen, W., and Bujard, H. Transcriptional activation by tetracyclines in mammalian cells. Science (Washington DC), 268: 1766-1769, 1995.
21. Schwab, M. K., Alitalo, H. E., Varmus, H. E., Bishop, J. M., and George, D. A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells. Nature (Lond.), 303: 497-501, 1983.
22. Barnard, J. A., Beauchamp, R. D., Coffey, R. J., and Moses, M. L. Regulation of intestinal epithelial cell growth by transforming growth factor type β. Proc. Natl. Acad. Sci. USA, 86: 1578-1582, 1989.
23. Al-Tubuly, A. A., Spijker, R., Pignatelli, M., Kirkland, S. C., and Ritter, M. A. Inhibition of growth and enhancement of differentiation of colorectal carcinoma cell lines by Mab and IL-4. Int. J. Cancer, 71: 605-611, 1997.
24. DuBois, R. N., Awad, J., Morrow, J., Roberts, L. J., II, and Bishop, P. R. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin. Invest., 93: 493-498, 1994.
25. Morrow, J. D., Minton, T. A., Mukundan, C. R., Campbell, M. D., Zackert, W. E., Daniel, V. C., Badr, K. F., Blair, I. A., and Roberts, L. J., II. Free radical-induced generation of isoprostanes in vivo, evidence for the formation of D-ring and E-ring isoprostanes. 269: 4317-4326, 1994.
26. 2 in human urine. J. Biol. Chem., 263: 16619-16625, 1988.
27. Asciak-Pace, R. R. Advances in Prostaglandin, Thromboxane, and Leukotriene Research. Mass Spectra of Prostaglandins and Related Products. In: B. Samuelsson and R. Paoletti (eds.), Vol. 18, pp. 382-386. New York: Raven Press, 1989.
28. Hanif, R., Pittas, A., Feng, Y., Kuotsos, M., Qiao, L., Staiano-Coico, L., Shiff, S. I., and Rigas, B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol., 52: 237-245, 1996.
29. Qia, L., Kozoni, V., Tsioulias, G. J., Koutsos, M. I., Hanif, R., Shiff, S. J., and Rigas, B. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochem. Biophys. Acta, 1258: 215-223, 1995.
30. 1 of haem oxygenase in myoblastic cells: an effect independent of expression of the 70 kDa heat shock protein. Biochem. J., 308: 455-463, 1995.
31. 1: an effect associated with heat shock transcription factor activation. Proc. Natl. Acad. Sci. USA, 94: 746-750, 1997.
32. 2 is a ligand for the adipocyte determination factor PPARγ Cell, 83: 803-812, 1995.
33. 2 metabolite binds peroxisome proliferator-activated receptor y and promotes adipocyte differentiation. Cell, 83: 813-819, 1995.
34. Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C., and Spiegelman, B. M. Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nat. Med., 4: 1046-1052, 1998.
35. Saez, E., Tontonoz, P., Nelson, M. C., Alvarez, J. G. A., T. M., Baird, S. M., Thomazy, V. A., and Evans, R. M. Activators of the nuclear receptor PPARγ enhance colon polyp formation. Nat. Med., 4: 1058-1062, 1998.
36. Brockman, J. A., Gupta, R. A., and DuBois, R. N. Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology, 115: 1049-1055, 1998.